International Workshop Focuses on Aging with Multiple Sclerosis
May 28, 2024 Almost half of all people living with MS today are 55 years of age or older, and…
Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses
Jacquelyn Bainbridge, PharmD; Rebecca Barnhart, PharmD; Ryan Fuller, PharmD; Van T. Hellerslia, PharmD; Julie Kidd, PharmD; Steven Merrill, PharmD; Emily…
Stuart Schlossman
Primary progressive MS confirmed as own disorder in mouse study
Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS by Marisa Wexler, MS | February 7, 2023…
Stuart Schlossman
Primary progressive MS confirmed as own disorder in mouse study
by Marisa Wexler, MS | February 7, 2023 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS…
Stuart Schlossman
Large study finds greater risk of Infection with progressive forms than RRMS
by Patricia Valerio, PhD | October 20, 2022 People with progressive forms of multiple sclerosis (MS) are nearly four times more likely…
Stuart Schlossman
Advances in Progressive Multiple Sclerosis
AAN Expert Exchange: Advances in Progressive Multiple Sclerosis June 22, 2022 Barry Hendin, MD, Regina Berkovich, MD, PhD, Ahmed Obeidat,…
Stuart Schlossman
New Research Finds That, For The First Time Ever, Stem Cell Treatments Improve Disability Status for Multiple Sclerosis Patients With Progressive Disease
Preliminary analysis of FDA-approved study conducted by the Tisch MS Research Centerof New York found that stem cell treatments substantially improved…
Stuart Schlossman
Sweden, Like France, OKs Start of Masitinib Trial in Progressive MS
Feb. 7th, 2022 The Swedish Medical Products Agency has approved AB Science’s request to launch in the country a confirmatory…
Stuart Schlossman
Phase 4 Trial Will Test if Ocrevus Can Prevent MS Onset in RIS Patients
Yale University is launching CELLO, a multicenter study to investigate the efficacy of Ocrevus (ocrelizumab) in treating people with lesions suggestive of multiple sclerosis (MS),…
Stuart Schlossman
High-Dose Biotin Fails in MS Trial
Click HERE to Subscribe for the MS Beacon Newsletter reported by : Cherie C Binns RN MSCN — Neither primary nor…
Stuart Schlossman
